Scandinavian Real Heart
14.20 SEK
-1.05 %
Less than 1K followers
HEART
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-1.05 %
-8.68 %
-26.42 %
+3.65 %
+19.73 %
-4.70 %
-89.73 %
-94.71 %
-90.83 %
Scandinavian Real Heart operates in the medical technology sector. The company conducts research and development in observations of the physiology of the heart. The development of the company's product, a complete artificial heart, is taking place in collaboration with cardiac surgeons, researchers and engineers. The focus is on developing patented solutions that can imitate the blood circulation of the natural human heart, with the goal of being used by patients diagnosed with heart failure. The company was founded in 2007.
Read moreMarket cap
141.96M SEK
Turnover
42.31K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
16/12
2025
Extraordinary general meeting '25
19/2
2026
Annual report '25
28/5
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
Realheart rapporterar insiderköp av aktien inom bolagets styrelse
Scandinavian Real Heart AB ändrar datum för extra bolagsstämma
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools